Skip to main content

Table 2 Baseline data and presentation of pediatric anaphylaxis patients

From: Downstream consequences of diagnostic error in pediatric anaphylaxis

 

Overall (n = 211)

n(%)

ED Dx anaphylaxis (n = 105)

n(%)

ED NOT Dx anaphylaxis (n = 106)

n(%)

Odds ratio (95% CI)

P value

Demographics

 Age in years, median (IQR)

6 (2–11)

6 (3–11.5)

5 (2–10.3)

N/A

0.18

 Boys, n (%)

131 (62.1)

64 (60.9)

67 (62.2)

N/A

0.74

Allergen class

 Food

173 (82.0)

91 (86.7)

82 (77.4)

N/A

0.35

 Drugs

8 (3.8)

3 (2.9)

5 (4.7)

 Insect

2 (0.9)

1 (0.9)

1 (0.9)

 Other / unknown

28 (13.3)

10 (9.5)

18 (16.9)

Organ system involved

 Cutaneous

203 (96.2)

97 (92.4)

105 (99.1)

0.12 (0.02–0.94)

0.02

 Respiratory

159 (75.3)

70 (66.7)

89 (84.0)

0.38 (0.20–0.74)

< 0.01

 Gastrointestinal

53 (25.1)

32 (30.5)

21 (19.8)

1.77 (0.94–3.34)

0.08

 Cardiovascular

23 (10.9)

14 (13.3)

9 (8.5)

1.66 (0.68–4.02)

0.28

 Neurological

27 (12.8)

19 (18.1)

8 (7.5)

2.71 (1.13–6.50)

0.02

 Median (IQR) number of organ systems involved during episode

2 (2–2)

2 (2–2)

2 (2–3)

N/A

0.62

 Median (IQR) number of organ systems involved at time of ED arrival

1 (0–1)

1 (0–1)

1 (0–2)

N/A

0.29

 At least one organ system resolved prior to ED

157 (74.4)

68 (64.7)

89 (83.4)

0.35 (0.18–0.68)

0.001

 All symptoms resolved prior to ED arrival

60 (28.4)

28 (26.7)

32 (30.2)

0.84 (0.45–1.54)

0.65

Severe anaphylaxis

28 (13.3)

20 (19.0)

8 (7.5)

2.88 (1.21–6.88)

0.02